SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.309
AS - Asia 21.413
EU - Europa 15.248
SA - Sud America 3.635
Continente sconosciuto - Info sul continente non disponibili 1.322
AF - Africa 499
OC - Oceania 74
AN - Antartide 1
Totale 78.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.057
SG - Singapore 8.154
FI - Finlandia 4.767
CN - Cina 4.509
IT - Italia 3.381
BR - Brasile 2.809
VN - Vietnam 2.317
DE - Germania 1.988
HK - Hong Kong 1.714
BD - Bangladesh 1.368
GB - Regno Unito 987
FR - Francia 773
UA - Ucraina 734
TR - Turchia 646
JP - Giappone 630
CA - Canada 623
IN - India 530
PL - Polonia 504
RU - Federazione Russa 451
SE - Svezia 432
ID - Indonesia 411
MX - Messico 376
NL - Olanda 303
AR - Argentina 275
ZA - Sudafrica 186
ES - Italia 184
IQ - Iraq 181
CO - Colombia 144
EC - Ecuador 133
PK - Pakistan 133
AT - Austria 130
BE - Belgio 99
VE - Venezuela 81
LT - Lituania 79
PH - Filippine 78
SA - Arabia Saudita 78
UZ - Uzbekistan 78
MY - Malesia 76
AU - Australia 67
KR - Corea 67
IE - Irlanda 66
JM - Giamaica 64
CH - Svizzera 58
MA - Marocco 58
CL - Cile 54
CZ - Repubblica Ceca 54
AE - Emirati Arabi Uniti 49
EG - Egitto 48
PY - Paraguay 43
TN - Tunisia 43
JO - Giordania 41
KE - Kenya 41
PE - Perù 38
NP - Nepal 37
UY - Uruguay 35
IR - Iran 33
AL - Albania 32
TH - Thailandia 32
CR - Costa Rica 28
DZ - Algeria 26
NI - Nicaragua 25
HN - Honduras 24
KZ - Kazakistan 24
LB - Libano 24
PT - Portogallo 23
DO - Repubblica Dominicana 22
TW - Taiwan 22
IL - Israele 21
AZ - Azerbaigian 20
KG - Kirghizistan 20
HR - Croazia 19
RO - Romania 19
SN - Senegal 19
ET - Etiopia 18
OM - Oman 18
GT - Guatemala 16
PA - Panama 16
PS - Palestinian Territory 16
MD - Moldavia 15
RS - Serbia 15
BG - Bulgaria 14
DK - Danimarca 14
SV - El Salvador 14
CY - Cipro 13
HU - Ungheria 13
SI - Slovenia 13
TT - Trinidad e Tobago 12
BO - Bolivia 11
GE - Georgia 11
BH - Bahrain 9
GR - Grecia 9
LV - Lettonia 9
NO - Norvegia 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
CI - Costa d'Avorio 8
XK - ???statistics.table.value.countryCode.XK??? 8
BY - Bielorussia 7
GY - Guiana 7
KW - Kuwait 7
Totale 77.015
Salva come PNG Salva come JPEG
Città #
Singapore 4.929
Ashburn 4.853
Helsinki 4.367
San Jose 3.305
Fairfield 2.306
Woodbridge 1.819
Hong Kong 1.671
Santa Clara 1.602
Beijing 1.420
Dallas 1.412
Council Bluffs 1.355
Houston 1.262
Chandler 1.030
Munich 1.024
Seattle 992
New York 936
Wilmington 856
Los Angeles 819
Ann Arbor 810
Jacksonville 776
Cambridge 766
Ho Chi Minh City 764
Tokyo 595
Hanoi 521
Warsaw 473
Milan 449
Lauterbourg 412
Ferrara 390
Izmir 344
Princeton 325
São Paulo 310
Jakarta 296
Shanghai 290
Nanjing 272
Chicago 235
London 222
Mexico City 216
Toronto 216
Orem 215
Buffalo 214
San Diego 214
Rome 206
Phoenix 200
Turku 187
Bologna 184
Boardman 181
Frankfurt am Main 160
Montreal 158
Atlanta 142
Brooklyn 141
Chennai 131
Denver 131
Hefei 121
Nuremberg 119
Rio de Janeiro 112
San Francisco 108
The Dalles 106
Da Nang 104
Amsterdam 102
Haiphong 102
Boston 97
Stockholm 97
Brussels 96
Johannesburg 94
Moscow 94
Tianjin 89
Manchester 84
Washington 84
Poplar 81
Bremen 79
Shenyang 78
Falkenstein 73
Mumbai 73
Nanchang 72
Tashkent 69
Baghdad 64
Redwood City 64
Lappeenranta 63
Falls Church 62
Naples 62
Columbus 61
Salt Lake City 60
Ankara 58
Paris 57
Jiaxing 55
Belo Horizonte 54
Dhaka 54
Guangzhou 54
Quito 53
Dublin 52
Charlotte 51
Medellín 49
Newark 49
Turin 49
Biên Hòa 48
Changsha 48
Brasília 44
Mountain View 44
Shenzhen 44
Vienna 44
Totale 50.581
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 2.877
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.064
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 439
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 437
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 435
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 382
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 379
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 368
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 359
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 355
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 343
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 326
Poor response to clopidogrel: current and future options for its management 310
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 309
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 303
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 299
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 289
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 287
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 282
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 281
Reperfusion Damage - A Story of Success, Failure, and Hope 271
Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study 270
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 270
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 268
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 266
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 264
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI 263
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 260
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 260
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 258
Characterization of Dermal Stem Cells of Diabetic Patients 257
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 254
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 253
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 252
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 251
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 249
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 248
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 247
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 247
The Mitochondrial Permeability Transition Pore 245
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 242
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 242
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 241
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 241
Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trial 237
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 236
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 236
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 235
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 234
Mechanistic role of mPTP in ischemia-reperfusion injury 232
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 229
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 229
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 228
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 227
A serum proteome signature to predict mortality in severe COVID-19 patients 227
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 227
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 225
Can we improve myocardial protection during ischaemic injury? 225
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 225
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 223
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 222
BRS implantation in long lesions requiring device overlapping: Myth or reality? 221
Drug-based cardiovascular prevention in patients with Marfan Syndrome: a systematic review 220
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 220
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 220
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 218
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 216
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 214
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 213
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 213
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 212
Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions 211
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 211
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 211
The Use of Multimodality Imaging for the Diagnosis of Myocardial Outpouchings and Invaginations: A Systematic Review 210
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 210
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease 210
Structural Abnormalities in Brugada Syndrome and Non-Invasive Cardiac Imaging: A Systematic Review 209
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 208
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 208
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 208
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 207
Notch Signaling Regulates Immune Responses in Atherosclerosis 206
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 205
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 205
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 204
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 203
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 203
Fractional flow reserve: Current applications and overview of the available data 201
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 201
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 201
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 200
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 200
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 200
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 200
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 199
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 199
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 198
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 198
A Nutraceutical Compound Containing a Low Dose of Monacolin K, Polymethoxyflavones, Phenolic Acids, Flavonoids, and Hydroxytyrosol Improves HDL Functionality 197
Totale 29.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 359.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.250
Totale 362.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.591 0 0 205 146 146 163 193 194 142 239 336 827
2022/20232.767 339 126 140 234 399 393 176 250 360 71 190 89
2023/20242.789 168 292 130 91 214 490 131 281 67 128 142 655
2024/202512.625 313 330 918 578 1.421 1.209 805 707 2.312 1.298 1.507 1.227
2025/202639.276 2.965 1.572 3.297 3.853 4.737 2.082 3.620 1.940 7.203 3.889 2.445 1.673
2026/20274.559 1.451 2.216 892 0 0 0 0 0 0 0 0 0
Totale 78.501